Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
Current Oncology (Toronto, Ont.)|May 3, 2019
The economic impact of the transition from branded to generic oncology drugsW Y Cheung, E A Kornelsen, N Mittmann, et al.
Neuron|October 31, 2000
Presenilin-mediated modulation of capacitative calcium entryA S Yoo, I Cheng, S Chung, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 24, 2016
[Quantities and function of NK cells in patients with positive BMMNC-Coombs test and cytopenia]X Yuan, R Fu, H Liu, et al.
Gynecologic Oncology|May 1, 2022
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometriumC G Jackson, K N Moore, L Cantrell, et al.
Gynecologic Oncology|November 6, 2025
Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovaryC Washington, Shailendra Kumar Dhar Dwivedi, C Gunderson-Jackson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2025
A randomized Phase II trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) brachytherapy as monotherapy in localized prostate cancer: analysis of initial arms of Canadian cancer trials group PR19 (NCT02960087)G Morton, E Vigneault, M Barkati, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 20, 2022
[Clinical characteristics and prognosis of 49 newly diagnosed primary central nervous system diffuse large B-cell lymphoma]J Song, H Liu, H L Shen, et al.
Physical Review. E|June 19, 2025
Dynamic stabilization and parametric excitation of instabilities in an ablation front by a temporally modulated laser pulseK G Zhao, J W Li, L F Wang, et al.
Plos One|February 8, 2014
Whole-genome array CGH evaluation for replacing prenatal karyotyping in Hong KongAnita S Y Kan, Elizabeth T Lau, W F Tang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017
Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trialsR Yerushalmi, B Dong, J W Chapman, et al.
Pageof 17